Q3 2025 Earnings Call October 27, 2025 8:45 AM EDTCompany ParticipantsChethan MallelaRobert GamgortTimothy Cofer - CEO ...
Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed.
Taylor Tepper covered banking, investing and pretty much everything else in personal finance for more than a decade, with his work appearing in the New York Times, Fortune and MONEY magazine, as well ...
Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results